Novo Nordisk A/S – Strategy, SWOT and Corporate Finance Report

Novo Nordisk A/S – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Novo Nordisk AS (Novo Nordisk or 'the company') is a pharmaceutical company that manufactures and develops biological medicines primarily focused on diabetes including both Type 1 and Type 2. Other therapy areas covered by the company include obesity, Atherosclerosis, Non-alcoholic steatohepatitis (NASH), Haemophilia, and growth disorders. Apart from this, the company also carries out extensive research for the cure of diseases like Parkinson’s, chronic heart failure and kidney failure. The company’s major products across different therapy areas include Tresiba, Ryzodeg, Fiasp, NovoRapid, Levemir, Insulatard, NovoPen, Saxenda, NordiPen, Activelle, Vagifem and others. Novo Nordsik has operations across North America, Asia, Europe, Middle East and Africa. It is headquartered in Bagsvaerd, Denmark.

Scope

– Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis

– An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments

– Intelligence on Novo Nordisk A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Novo Nordisk A/S's business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Novo Nordisk A/S: Company Overview

Novo Nordisk A/S: Overview and Key Facts

Novo Nordisk A/S: Overview

Novo Nordisk A/S: Key Facts

Novo Nordisk A/S: Key Employees

Novo Nordisk A/S: Key Employee Biographies

Novo Nordisk A/S: Major Products and Services

Novo Nordisk A/S: Company History

Novo Nordisk A/S: Management Statement

Novo Nordisk A/S: Locations and Subsidiaries

Novo Nordisk A/S: Key Competitors

Novo Nordisk A/S: Company Analysis

Novo Nordisk A/S: Business Description

Novo Nordisk A/S: SWOT Analysis

Novo Nordisk A/S: SWOT Overview

Novo Nordisk A/S: Strengths

Novo Nordisk A/S: Weaknesses

Novo Nordisk A/S: Opportunities

Novo Nordisk A/S: Threats

Novo Nordisk A/S: Corporate Financial Deals Activity

Novo Nordisk A/S: Financial Deals Overview

Novo Nordisk A/S: Targets and Partners

Novo Nordisk A/S: Top Deals 2015 - 2019YTD*

Novo Nordisk A/S: Advisors

Novo Nordisk A/S: Top Legal Advisors

Novo Nordisk A/S: Top Financial Advisors

Novo Nordisk A/S: Mergers and Acquisitions

Novo Nordisk A/S: Corporate Venturing

Novo Nordisk A/S: Partnership

Novo Nordisk A/S: Divestments

Novo Nordisk A/S: Recent Developments

Novo Nordisk A/S: News and Events Summary

Novo Nordisk A/S: Business Expansion

Novo Nordisk A/S: Contracts

Novo Nordisk A/S: Market Developments

Novo Nordisk A/S: Red Flags/DistressSignals

Novo Nordisk A/S: Regulatory and Legal Events

Novo Nordisk A/S: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Novo Nordisk A/S: Key Facts

Table 2: Novo Nordisk A/S: Key Employees

Table 3: Novo Nordisk A/S: Company History

Table 4: Novo Nordisk A/S: Locations and Subsidiaries

Table 5: Novo Nordisk A/S: Key Competitors

Table 6: Novo Nordisk A/S: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Novo Nordisk A/S: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Table 8: Novo Nordisk A/S: M&A Average Deal Size – Value (US$m)

Table 9: Novo Nordisk A/S: Targets and Partners

Table 10: Novo Nordisk A/S: Top Deals 2015 – 2019YTD*

Table 11: Novo Nordisk A/S: Legal Advisor Ranking by Value (US$m)

Table 12: Novo Nordisk A/S: Financial Advisor Ranking by Value (US$m)

Table 13: Novo Nordisk A/S: M&A Volume and Value Trend (2015 – YTD*2019)

Table 14: Novo Nordisk A/S: M&A Activity by Geography (2015 – YTD*2019)

Table 15: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Table 16: Novo Nordisk A/S: Corporate Venturing by Geography (2015 – YTD*2019)

Table 17: Novo Nordisk A/S: Partnership Volume and Value Trend (2015 – YTD*2019)

Table 18: Novo Nordisk A/S: Partnership Trend by Deal Type (2015 – YTD*2019)

Table 19: Novo Nordisk A/S: Divestments Volume and Value Trend (2015 – YTD*2019)

Table 20: Novo Nordisk A/S: Divestments by Geography (2015 – YTD*2019)

Table 21: Novo Nordisk A/S: News and Events Summary

Table 22: Novo Nordisk A/S: Business Expansion

Table 23: Novo Nordisk A/S: Contracts

Table 24: Novo Nordisk A/S: Market Developments

Table 25: Novo Nordisk A/S: Red Flags/DistressSignals

Table 26: Novo Nordisk A/S: Regulatory and Legal Events

Table 27: Novo Nordisk A/S: Strategy and Operations

List of Figures

List of Figures

Figure 1: Novo Nordisk A/S: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Novo Nordisk A/S: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Figure 3: Novo Nordisk A/S: M&A Average Deal Size – Value (US$m)

Figure 4: Novo Nordisk A/S: M&A Volume and Value Trend (2015 – YTD*2019)

Figure 5: Novo Nordisk A/S: M&A Activity by Geography (2015 – YTD*2019)

Figure 6: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Figure 7: Novo Nordisk A/S: Corporate Venturing by Geography (2015 – YTD*2019)

Figure 8: Novo Nordisk A/S: Partnership Volume and Value Trend (2015 – YTD*2019)

Figure 9: Novo Nordisk A/S: Partnership Trend by Deal Type (2015 – YTD*2019)

Figure 10: Novo Nordisk A/S: Divestments Volume and Value Trend (2015 – YTD*2019)

Figure 11: Novo Nordisk A/S: Divestments by Geography (2015 – YTD*2019)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports